The global nicotinamide adenine dinucleotide (NAD) market, valued at USD 535.53 million in 2022 and projected to grow at a compound annual growth rate (CAGR) of 12.41% over the forecast period, is experiencing accelerated expansion driven by increasing scientific validation of NAD’s role in cellular metabolism, aging, and mitochondrial function. This growth is not uniform across...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek